Premium
Functional angiotensin‐converting enzyme 2 is expressed in human cardiac myofibroblasts
Author(s) -
Guy Jodie L.,
Lambert Daniel W.,
Turner Anthony J.,
Porter Karen E.
Publication year - 2008
Publication title -
experimental physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.925
H-Index - 101
eISSN - 1469-445X
pISSN - 0958-0670
DOI - 10.1113/expphysiol.2007.040139
Subject(s) - angiotensin converting enzyme 2 , angiotensin ii , myofibroblast , angiotensin converting enzyme , renin–angiotensin system , biology , enzyme , medicine , microbiology and biotechnology , endocrinology , ectodomain , chemistry , receptor , fibrosis , biochemistry , covid-19 , blood pressure , infectious disease (medical specialty) , disease
The renin–angiotensin system (RAS), in particular angiotensin II, plays an important role in cardiac remodelling. Angiotensin‐converting enzyme (ACE) and angiotensin‐converting enzyme 2 (ACE2) are key players in the RAS and act antagonistically to regulate the levels of angiotensin II. In this study, we reveal the functional expression of ACE2 in human cardiac myofibroblasts, cells that are essential to the maintenance of normal cardiac architecture and also play a key role in myocardial remodelling. The observed reciprocal expression of ACE and ACE2 in these cells may reflect the possible opposing activity of these two enzymes. In this study, we demonstrate the presence of ACE2 as an ectoenzyme and reveal that ACE2 undergoes phorbol‐12‐myristate‐13‐acetate‐inducible ectodomain shedding from the membrane. When cells were exposed to a number of pathophysiological stimuli, modulation of ACE2 levels was not detected. Importantly, whilst we found ACE2 to be expressed constitutively in cardiac myofibroblasts there were no detectable levels in either vascular smooth muscle cells or vascular endothelium, indicating that ACE2 expression is not ubiquitous. In paraffin sections of atrial appendage tissue, we observed a distinct staining pattern for ACE2 which appeared different from that of ACE. In conclusion, this study is the first to report co‐expression of ACE and ACE2 in human cardiac myofibroblasts and may therefore present a model primary system for study of the comparative cell biology of ACE2 and ACE and their potentially opposing roles in myocardial remodelling.